$BHC BUYS. Good time for pharma!Key Stats:
Market Cap: $4.4B
Revenue (TTM): $11.82B
EBITDA Margi
Debt: $29.05B (High, but manageable with recent restructuring efforts)
Technical Indicators:
1️⃣ 50-Day and 200-Day Moving Average Crossover: BHC is trending above its 200-day moving average, showing long-term bullish momentum.
2️⃣ RSI Neutral : No signs of overbought territory, providing room for further upside without a pullback.
3️⃣ Strong Support Zone: Key support held firmly, suggesting bulls are defending this level.
Fundamental Indicators:
1️⃣ Valuation Play: BHC is undervalued relative to its industry, despite consistent revenues of $11.82B annually. The EV/EBITDA ratio of 8.1 confirms a bargain price.
2️⃣ Operational Efficiency: EBITDA margins at 34.5% and an operating cash flow of $1.01B indicate strong cash-generating ability, even under high debt loads.
3️⃣ Catalyst Potential: Patent dispute resolutions and potential drug approvals could act as significant tailwinds for revenue growth and investor sentiment.
Potential Path to Profit:
1️⃣ Lowest Risk: Buy shares outright at current levels.
Disclaimer: We are not a brokerage or investment firm. This is not financial advice. All sales are final.
BHC trade ideas
BHC panic!It appears that shareholders are overreacting to recent news. It is unclear whether the publisher and their associates profited from this misinformation. A thorough investigation is warranted to determine the facts and assess any potential impact on the market. Given the current fragile state of the market, even a minor event could trigger a significant selloff, which could present an opportunity for savvy investors.
$BHC - LongThis stock has horrifically bad spreads, i usually stay away from trash like this but reviewing trading data from this month i'm seeing extremely big activity behind this stock. I also checked around and apparently Jim Cramer is bearish this stock within the same month as said same extremely trading activity. Due to these nice 2 conflicting things i've gone ahead and went long this stock.
BAUSCH HEALTH COMPANIES Chart DailyHey guys, BAUSCH HEALTH COMPANIES is in a bullish configuration with a hammer candle shape and past buy volume return. Looking at the TIMEFRAME M1 we see a kind of hammer candle with a large volume of purchases traded, it has come to test the lowest bollinger. And start again on its highest which is the test of the consolidation zone. There is a good chance of breaking the cost of both the area to access the high that follows. With excess on the last precedent higher (on TIMEFRAME H4) Three higher (before TIMEFRAME D1).
After excess to breakout the zone, little power to test the middle of the intermediate median of ANDREWS PITCHFORK.
Please LIKE & FOLLOW, thank you!